Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Pleural infection

Respiratory · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Sepsis, hypoxaemia, shock, rapidly enlarging collection or tension pyothorax requires immediate senior respiratory, microbiology and critical-care support. Start appropriate intravenous antibiotics and achieve source control without waiting for culture; use image-guided drainage unless immediate life-saving decompression is required.

Synopsis

Identify complicated parapneumonic effusion or empyema early, use pleural chemistry and imaging correctly, and combine antibiotics with prompt effective drainage and timely surgical escalation.

  • Pleural infection includes complicated parapneumonic effusion and empyema; pus or organisms in pleural fluid establishes the need for drainage regardless of pH.
  • Persistent fever, pleuritic pain or sepsis despite pneumonia treatment should prompt thoracic ultrasound, even when the chest radiograph shows only basal shadowing.
  • Use ultrasound guidance for aspiration and drain placement. Septations and echogenic fluid support complexity but do not replace fluid analysis.
  • Measure pleural pH immediately in a heparin-free blood-gas syringe without local-anaesthetic contamination. Air, delay and lidocaine can materially distort the result.
  • In non-purulent fluid, pH at or below 7.20 indicates high risk and usually warrants a drain if safely accessible. Intermediate pH requires LDH, glucose, imaging and clinical context under the BTS pathway.
  • Send pleural fluid in both sterile containers and inoculated blood-culture bottles to improve microbiological yield, alongside cytology when malignancy remains possible.
  • Start antibiotics covering likely community- or hospital-acquired organisms and anaerobes, then narrow to cultures and clinical response. Duration is individualised and usually extends beyond initial intravenous therapy.
  • A small-bore chest tube is usually adequate initially when positioned in the collection and flushed according to protocol.
  • If drainage has stopped with residual collection, combined intrapleural tPA and DNase can improve drainage; do not use either agent alone as a substitute.
  • Failure of sepsis and collection to improve requires early thoracic-surgical review. Do not wait for prolonged organ failure before discussing VATS.

Key red flags

Complicated parapneumonic effusion

Pneumonia with persistent fever, pleuritic pain, systemic inflammation and a pleural collection whose low pH, low glucose, high LDH or septation predicts failure of antibiotics alone.

Empyema

Frank pus, a positive pleural culture or a thick infected collection establishes pleural infection and requires drainage plus antibiotics.

Hospital-acquired pleural infection

Recent surgery, aspiration, hospital pneumonia or pleural instrumentation increases resistant Gram-negative and staphylococcal risk and changes empirical antibiotics.

Ongoing source-control failure

Persistent sepsis, inflammatory markers or residual loculated fluid despite a patent drain suggests malposition, obstruction, separate locules, bronchopleural fistula or organised disease.

Alternative infected cavity

Lung abscess, infected bulla, subphrenic collection, oesophageal leak or malignant effusion can mimic empyema and make blind drainage hazardous.

Investigation priorities

01
Chest radiograph and thoracic ultrasoundFirst step

Confirm pleural fluid, estimate volume and complexity, and identify a safe sampling or drain site.

Management branches

Initial assessmentFind complicated fluid early

Pneumonia has pleural fluid, persistent sepsis or pleuritic pain.

  1. Assess sepsis severity, oxygenation and organ function, start appropriate antibiotics promptly and request respiratory or pleural review.
  2. Use thoracic ultrasound to confirm fluid and perform image-guided aspiration when the result will change drainage.
  3. Send immediate pH, microbiology, glucose, LDH and other tests required by the differential.
  4. Drain frank pus, positive microbiology or high-risk biochemical fluid when safely accessible.

Key medicines

Empirical antimicrobial therapyStart intravenous treatment promptly using the current local pleural-infection guideline, distinguishing community from hospital acquisition and including anaerobic cover where indicated.Adjust for allergy, renal and liver function, resistant-organism risk and cultures. Review route and total duration with microbiology; antibiotics alone are inadequate for frank pus or high-risk complicated fluid.
Intrapleural alteplase plus dornase alfaA BTS-supported adult regimen is alteplase 10 mg plus dornase alfa 5 mg intrapleurally twice daily for three days; use the current local protocol and consider reduced alteplase in higher bleeding risk.This is specialist, consented intrapleural use. Assess bleeding risk and anticoagulation; pain and pleural bleeding occur. Do not substitute either drug alone or administer by the wrong route.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BTS Guideline for Pleural DiseaseCurrent pH-based drainage, intrapleural treatment and surgical-escalation guidance.
  • BTS Clinical Statement on Pleural ProceduresSampling, ultrasound, drain, flushing and intrapleural-drug safety.
  • NICE NG250 pneumonia diagnosis and managementCurrent adult pneumonia severity, antimicrobial and reassessment framework.
  • BTS Quality Standard for Pleural DiseasePublished 2026; access, diagnostic and procedure quality standards.
  • BNF dornase alfa monographCurrent medicine safety and formulation reference; pleural use follows specialist BTS/local protocol.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom